Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SPI1 |
| Upstream (Parents) |
|---|
| (<<) PITX2 → SPI1 |
| (<<) ZNF215 → SPI1 |
| (<<) CBFA2T3 → SPI1 |
| (<<) TFEC → SPI1 |
| (<<) HCLS1 → SPI1 |
| (<<) CREB5 → SPI1 |
| Downstream (Children) |
|---|
| SPI1 → GATA3 (>>) |
| SPI1 → ARNT2 (>>) |
| SPI1 → TLX1 (>>) |
| SPI1 → RUNX2 (>>) |
| SPI1 → ZNF132 (>>) |
| SPI1 → FOXA1 (>>) |
| SPI1 → PKNOX1 (>>) |
| SPI1 → GAS7 (>>) |
| SPI1 → RARA (>>) |
| SPI1 → HNF4G (>>) |
| SPI1 → YY1 (>>) |
| SPI1 → THRB (>>) |
| SPI1 → SATB1 (>>) |
| SPI1 → BATF3 (>>) |
| SPI1 → BCL3 (>>) |
| SPI1 → VAV1 (>>) |
